Generalized pustular figurate erythema first report in two COVID‐19 patients on hydroxychloroquine
| Autor: | P A Cerro, A M Morales-Callaghan, A M Palma-Ruiz, I Abadías-Granado, M C Gómez-Mateo, Yolanda Gilaberte, Robert A. Schwartz |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Hydroxychloroquine Dermatology medicine.disease 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Infectious Diseases 030220 oncology & carcinogenesis medicine Figurate erythema Drug reaction business Generalized pustular medicine.drug |
| Zdroj: | Journal of the European Academy of Dermatology and Venereology |
| ISSN: | 1468-3083 0926-9959 |
| DOI: | 10.1111/jdv.16903 |
| Popis: | Generalized pustular figurate erythema (GPFE) is a distinctive severe cutaneous drug reaction with widespread urticarial or edematous plaques scattered over the entire body that become topped with non-follicular pustules that evolve into erythematous and sometimes atypical targetoid plaques converging into annular and arcuate patterns prominent on the trunk and extremities (1). It has been linked with medications, especially hydroxychloroquine. We describe two COVID-19 patients on hydroxychloroquine who developed this eruption 2 and 3 weeks after the onset of hydroxychloroquine. This report is the first to our knowledge of COVID-19 patients on hydroxychloroquine developing GPFE. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text